Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Panacea Life Sciences's ebitda for the twelve months ending Dec 31, 2016 was -$1.60M. For fiscal 2018 it was -$2.03M. The highest annual figure on record is -$387.66K in fiscal 2015.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | -$2.03M | – |
| FY2017 | Dec 31, 2017 | -$3.07M | – |
| FY2016 | Dec 31, 2016 | -$1.60M | – |
| FY2015 | Dec 31, 2015 | -$387.66K | – |
| FY2014 | Dec 31, 2014 | -$418.47K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2021 | Sep 30, 2021 | -$474.86K | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.45M | – |
| Q4 FY2016 | Dec 31, 2016 | -$747.43K | – |
| Q3 FY2016 | Sep 30, 2016 | -$359.81K | – |
| Q2 FY2016 | Jun 30, 2016 | -$260.87K | – |
| Q1 FY2016 | Mar 31, 2016 | -$233.37K | – |
| Q4 FY2015 | Dec 31, 2015 | -$69.40K | – |
| Q1 FY2015 | Mar 31, 2015 | -$63.42K | – |
| Q4 FY2014 | Dec 31, 2014 | -$239.97K | – |
| Q3 FY2014 | Sep 30, 2014 | -$74.45K | – |
| Q2 FY2014 | Jun 30, 2014 | -$16.67K | – |
See a number that looks wrong?